calcipotriene and betamethasone dipropionate

Product NDC
45802-889
11-digit product format
458020889
Labeler code
45802
Product ID
45802-889_a4d1e801-4f0d-426e-8bae-d3130ccc5944
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
calcipotriene and betamethasone dipropionate
Dosage form
SUSPENSION
Route
TOPICAL
Labeler
Padagis Israel Pharmaceuticals Ltd
Application
ANDA212367
Marketing category
ANDA
Marketing start
2020-10-09
Marketing end
0000-00-00
Substance
CALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE
Active strength
50 ug/g; mg/g
Pharmacologic classes
Vitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45802-889CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [PADAGIS ISRAEL PHARMACEUTICALS LTD]6Legacy NDC20240629_1359f4b2-60c9-42c9-8b25-9ef955ffeae5.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
45802-889-18458020889182 BOTTLE in 1 CARTON (45802-889-18) > 60 g in 1 BOTTLE2 bottle2020-10-090000-00-00NoNoCurrent
45802-889-96458020889961 BOTTLE in 1 CARTON (45802-889-96) > 60 g in 1 BOTTLE1 bottle2020-10-090000-00-00NoNoCurrent